Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists |
Mechanism ERK agonists(ERK subfamily agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC36H62O8 |
InChIKeyCKUVNOCSBYYHIS-IRFFNABBSA-N |
CAS Registry78214-33-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Heart Injuries | Preclinical | China | 06 Jun 2025 | |
Myocardial Infarction | Preclinical | China | 06 Jun 2025 | |
Sepsis-Associated Encephalopathy | Preclinical | China | 26 Aug 2024 |